Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

TTC39D Activators

Chemical activators of tetratricopeptide repeat domain 39D (TPRD39D) function through various intracellular signaling pathways to modulate its activity. Forskolin, by elevating intracellular cAMP levels through the activation of adenylate cyclase, leads to the activation of protein kinase A (PKA). PKA, in turn, can phosphorylate TPRD39D, thereby regulating its function. Similarly, IBMX, by preventing the degradation of cAMP, supports sustained PKA activity and subsequent phosphorylation of TPRD39D. Dibutyryl-cAMP, as a cell-permeable analog of cAMP, directly activates PKA, which can then phosphorylate and activate TPRD39D. Phorbol 12-myristate 13-acetate (PMA) operates through the activation of protein kinase C (PKC), which is known to phosphorylate a broad range of cellular proteins, including TPRD39D. Chelerythrine, while principally a PKC inhibitor, can activate other kinase pathways that may lead to TPRD39D activation. Ionomycin raises intracellular calcium levels and may activate calmodulin-dependent kinase (CaMK), which could also result in the phosphorylation of TPRD39D. The activation of TPRD39D could also be influenced by the inhibition of protein phosphatases PP1 and PP2A by compounds like Okadaic acid and Calyculin A, which prevent dephosphorylation, thereby maintaining TPRD39D in a phosphorylated, active state.

Furthermore, Epidermal Growth Factor (EGF) stimulates its receptor, triggering the MAPK/ERK pathway, which can phosphorylate TPRD39D as part of the signaling cascade. Anisomycin activates the JNK/SAPK pathway, which could lead to the activation of TPRD39D through phosphorylation events. In contrast, LY294002 and U0126, by inhibiting PI3 kinase and MEK respectively, might indirectly influence the activation state of TPRD39D through compensatory activation of alternative signaling pathways that converge on TPRD39D phosphorylation. These various chemical activators, through distinct yet converging pathways, modulate the phosphorylation status and activity of TPRD39D within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-specific inhibitor of phosphodiesterases, which prevents cAMP degradation, thereby sustaining PKA activity. This sustained activity may lead to the phosphorylation and consequent activation of tetratricopeptide repeat domain 39D.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC), which can phosphorylate and thereby activate tetratricopeptide repeat domain 39D or its associated regulatory components within its pathway.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent kinase (CaMK), possibly leading to the phosphorylation and activation of tetratricopeptide repeat domain 39D.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic acid inhibits protein phosphatases PP1 and PP2A, resulting in increased phosphorylation levels within the cell. This inhibition can lead to the activation of tetratricopeptide repeat domain 39D through enhanced phosphorylation.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin is an activator of the JNK/SAPK pathway, which can lead to phosphorylation and activation of downstream proteins, potentially including tetratricopeptide repeat domain 39D.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can then phosphorylate and activate tetratricopeptide repeat domain 39D.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Calyculin A is an inhibitor of protein phosphatases PP1 and PP2A, like Okadaic acid, leading to increased phosphorylation and potential activation of tetratricopeptide repeat domain 39D.

Chelerythrine

34316-15-9sc-507380
100 mg
$540.00
(0)

Chelerythrine is a potent inhibitor of protein kinase C (PKC), but it can also cause a compensatory activation of other kinase pathways, indirectly leading to the activation of tetratricopeptide repeat domain 39D.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3 kinase inhibitor, which can cause a compensatory feedback loop that activates AKT signaling, potentially resulting in the activation of tetratricopeptide repeat domain 39D.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is an inhibitor of MEK, which may lead to compensatory activation of alternative pathways that could involve the activation of tetratricopeptide repeat domain 39D.